Sign in
CompletedNo phase

Jewel Electrophysiology (EP) Lab Study

Key facts

Who runs it
Element Science, Inc.
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
18 people enrolled
Started
27 Nov 2018
Ended
17 Apr 2024
Type of study
Interventional
Treatments tested
  • Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
Record updated
27 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Subjects of both genders of at least 18 years of age
  • Subjects who are scheduled for a standard EP clinical procedure where fast VT or VF may spontaneously occur or may be induced

Who cannot take part

  • Subjects who have been diagnosed with heart failure (Class IV) or experienced an acute heart failure exacerbation within the previous 30 days
  • Subjects who are participating in an investigational study of a drug, biologic, or device not currently approved for marketing
  • Subjects who exhibit unstable angina
  • Subjects who are allergic to or have had a known adverse reaction to medical adhesives
  • Subjects who have active skin breakdown, erythema, or other signs of infection in the pectoral or torso regions where the study device is applied
  • Any condition that an Investigator believes would interfere with the intent of the study or is not in the best interest of the patient
  • Subjects who exhibit a left ventricular ejection fraction (LVEF) less than 20% (as assessed by techniques such as echocardiography, magnetic resonance imaging, or radionuclide angiography) within the last 6 months
  • Subjects who may require sterile access to the right upper pectoral or lower left torso regions during the planned EP procedure
  • Subjects who have taken amiodarone in the past 3 months
  • Subjects with an existing unipolar pacemaker
  • Subjects with atrial fibrillation with contraindication to anticoagulation or improper anticoagulation management
  • Subjects with a lower abdomen circumference of less than 68.5 cm or greater than 142 cm
  • Females who are pregnant or breastfeeding, or planning to be pregnant in the next 12 months
  • Subjects who cannot provide or have diminished capacity to provide informed consent
  • Any patient that according to the Declaration of Helsinki is unsuitable for enrollment

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Single arm open label evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) defibrillation waveform in adult cardiac patients.

The group in the trial

  • TreatmentTreatment being tested

    Safety and Effectiveness

    Treatment: Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
27 April 2026